Tech Company Financing Transactions
AMO Pharma Funding Round
AMO Pharma secured a $25 million venture capital round on 10/1/2015. Investors included Woodford Investment Management.
Transaction Overview
Company Name
Announced On
10/1/2015
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The financing will also be used to expand the AMO Pharma pipeline through acquisition of additional development-stage products.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2608 Erwin Rd. Box 212 148
Durham, NC 27705
USA
Durham, NC 27705
USA
Phone
Website
Email Address
Overview
AMO Pharma is a privately held emerging biopharmaceutical company developing new treatments for serious and debilitating diseases including rare genetic disorders. Our goal is to identify and advance a robust pipeline of promising therapies for patient populations with significant areas of unmet need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Snape
Chief Financial Officer
Martyn Williams
Chief Medical Officer
Joe Horrigan
VP - Bus. Development
Alison McMorn
Browse more venture capital transactions:
Prev: 10/1/2015: Qualpay venture capital transaction
Next: 10/1/2015: PeopleDoc venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs